Status:

COMPLETED

Iron Absorption From an Iron-fortified Follow-up Formula With Added Synbiotic or Human Milk Oligosaccharides

Lead Sponsor:

Société des Produits Nestlé (SPN)

Conditions:

Iron Absorption

Eligibility:

All Genders

40-56 years

Phase:

NA

Brief Summary

The co-primary objectives of this study are: 1) to investigate the effect adding a synbiotic (combination of a pre-and probiotic) to iron-fortified follow-up formula (FUF) on iron bioavailability, and...

Detailed Description

Iron stores of healthy, full-term neonates are supposed to cover iron needs for the first 4-6 months of life. After 6 months of age, requirements for absorbed iron are high, as infants need to build b...

Eligibility Criteria

Inclusion

  • Written informed consent has been obtained from the parents/legally acceptable representative
  • Child aged 40-56 weeks (± 3 weeks)
  • Child exhibits no clinical signs/symptoms of chronic disease or acute illness
  • Capillary Hb ≥70 g/L
  • Anticipated residence in the area for the study duration
  • Z-scores for weight-for-age and weight-for-length both \>-3, if the infant is severely underweight or severely malnourished.
  • Singleton, full-term gestation birth (≥37 weeks)
  • Birth weight ≥2.5 kg and ≤4.5 kg

Exclusion

  • Child exhibits clinical signs/symptoms of chronic infectious, metabolic, genetic illness or other disease including any condition that impacts feeding or growth
  • Child received vitamin and mineral supplements in the 2 weeks prior to enrollment
  • Child is exclusively breastfed
  • Child received antibiotic treatments in the 4 weeks prior to enrollment
  • Parents or caretakers not willing/not able to comply with the requirements of the study protocol
  • Child has allergy or intolerance to cows' milk protein or lactose, or severe food allergies
  • Child is participating in any other interventional clinical trial that would interfere with study outcomes

Key Trial Info

Start Date :

November 18 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 7 2021

Estimated Enrollment :

82 Patients enrolled

Trial Details

Trial ID

NCT04774016

Start Date

November 18 2020

End Date

June 7 2021

Last Update

March 24 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Amphawa Hospital

Samut Sakhon, Thailand